Target candidate with partial support; inspect missing evidence before prioritizing.
Automated synthesis of the evidence currently loaded. Review the underlying records before prioritizing this protein.
Main supporting evidence
Risks to review
Terms and data sources used on this page
PDB: experimentally determined structures from the Protein Data Bank. These are the strongest structural evidence, but may cover only part of the protein.
AlphaFold DB model: a precomputed predicted structure downloaded from AlphaFold Database/UniProt, not an experiment performed here.
ColabFold model: a predicted structure generated for this workspace; interpret it with coverage and confidence.
pLDDT: confidence score for predicted structures. High values support local geometry; low values mean the region should not drive pocket interpretation.
FPocket / P2Rank: software tools that predict possible ligand-binding pockets on a 3D structure. They are useful screening signals, not experimental validation.
Druggability: a pocket-based estimate of whether a small molecule could bind productively. It does not mean a drug already exists.
PDB ligand: a compound observed in an experimental structure. Direct same-protein records are stronger than homolog-transferred records.
ChEMBL: a public database of measured compound bioactivity. Direct entries are stronger than entries transferred from similar proteins.
ZINC: a purchasable-compound database. Here it marks proposed candidates from chemical similarity, not measured binders.
LigQ / LigQ_2: an internal Target pipeline step that gathers PDB, ChEMBL, and ZINC ligand evidence for each protein.
Off-target: sequence similarity to proteins we prefer not to hit, such as human proteins or beneficial gut microbiome proteins.
DEG: Database of Essential Genes. A match suggests the protein resembles genes known to be essential in other organisms.
Roary / CoreCruncher: pan-genome tools used to decide whether a gene is core across analyzed strains or accessory/strain-specific.
EC / GO: functional annotations: EC describes enzyme reactions; GO describes biological process, molecular function, or cellular component.
KEGG pathway: a curated metabolic route label used here to group reactions imported from the metabolic model.
Chokepoint: a metabolic reaction that is the only producer or consumer of a metabolite in the imported model.
Prioritization evidence
Selectivity, essentiality, structural confidence, conservation, and predicted binding-site evidence.
Off-target risk
- Human off-target
- Hit
- Human identity (%)
- 34.483 Lower values reduce human off-target concern.
- Human E-value
- 5.78e-79
- Gut microbiome similarity
- 1.6% of screened genomes Lower prevalence suggests narrower overlap with the screened gut microbiome.
Essentiality
- Essential (DEG)
- N
- DEG identity (%)
- 0.0 Higher values support similarity to known essential genes.
Localization
- Localization
- Periplasmic
Structure confidence
- ColabFold pLDDT
- 90.25 0-100 confidence; >70 supports local structural interpretation.
Binding-site evidence
AlphaFold DB / UniProt modelThe selected pocket score is the FPocket value used for ranking after applying the curated structure priority. It estimates small-molecule pocket quality; it is not experimental binding evidence. The 3D viewer may show a different loaded structure, so visible pockets can differ.
Cross-references
External database identifiers for this protein, its structures, ligands, and metabolic reactions.
Sequence
Sequence
Primary amino-acid sequence viewer.
MTSTDARRPAALPCSLRLAIGGALIALMSLNAQAEDGKTAPPPSPDILLGPLFNDVQSAKLFADQKTFADAIPNSDPLMILADYRMQKNQASFDLRHFVELNFTLPKENDTYVPPKGQTLRQHIDGLWPVLTRSTVEVEKWDSLLPLPKPYVVPGGRFREVYYWDSYFTMLGLAESGHWDKVEDMVANFAAEIDAWGHIPNGNRTYYLSRSQPPFFSFMVSLLATHDGDQVLKTYQPQLEKEYRYWMAGADALAPGSADKRAVRMADGALLNRYWDDNDTPRPESWLDDVKTAKSNPNRPATEIYRDLRSAAASGWDFSSRWMDNPQQLATIRTTSIVPVDLNALMFHLEKTLARASKASGDSAGATQYDALANARQQAIEKYLWNDKEGWYADYDLKSHKVRNQLTAAALFPLYVNAASRERATKVAAAAESRLLKPGGLTTTTVNSGQQWDAPNGWAPLQWVAVEGLQNYGQQKIAMEVTWRFLTNVQHTYDSKQKLVEKYDVSSTGTGGGGGEYPLQDGFGWTNGVTLKMLDLICPQEKPCDALPATRPATTPSPQDKPVAAPAANDPAPAEPQKTGS
Functional annotations
Enzyme classification and Gene Ontology terms linked to this protein.
Enzyme Commission (EC)
1Gene Ontology (GO)
6- GO:0042597 The region between the inner (cytoplasmic) and outer membrane (Gram-negative Bacteria) or cytoplasmic membrane and cell wall (Fungi and Gram-positive Bacteria).
- GO:0005975 The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y.
- GO:0071474 Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of detection of, or exposure to, a hyperosmotic environment, i.e. an environment with a higher concentration of solutes than the organism or cell.
- GO:0005991 The chemical reactions and pathways involving trehalose, a disaccharide that consists of two molecules of glucose and is isomeric with sucrose.
- GO:0004555 Catalysis of the reaction: alpha,alpha-trehalose + H2O = 2 D-glucose.
- GO:0005993 The chemical reactions and pathways resulting in the breakdown of trehalose, a disaccharide that consists of two molecules of glucose and is isomeric with sucrose.
Sequence domains and features
Domain and signature matches imported from InterPro and related databases.
Show feature table
| Start | End | DB | Term | Name |
|---|---|---|---|---|
| 1 | 34 | SignalP_EUK | SignalP-noTM | SignalP-noTM |
| 271 | 288 | PRINTS | PR00744 | Glycosyl hydrolase family 37 signature |
| 271 | 288 | InterPro | IPR001661 | Glycoside hydrolase, family 37 |
| 337 | 354 | PRINTS | PR00744 | Glycosyl hydrolase family 37 signature |
| 337 | 354 | InterPro | IPR001661 | Glycoside hydrolase, family 37 |
| 305 | 322 | PRINTS | PR00744 | Glycosyl hydrolase family 37 signature |
| 305 | 322 | InterPro | IPR001661 | Glycoside hydrolase, family 37 |
| 196 | 214 | PRINTS | PR00744 | Glycosyl hydrolase family 37 signature |
| 196 | 214 | InterPro | IPR001661 | Glycoside hydrolase, family 37 |
| 521 | 534 | PRINTS | PR00744 | Glycosyl hydrolase family 37 signature |
| 521 | 534 | InterPro | IPR001661 | Glycoside hydrolase, family 37 |
| 444 | 460 | PRINTS | PR00744 | Glycosyl hydrolase family 37 signature |
| 444 | 460 | InterPro | IPR001661 | Glycoside hydrolase, family 37 |
| 380 | 396 | PRINTS | PR00744 | Glycosyl hydrolase family 37 signature |
| 380 | 396 | InterPro | IPR001661 | Glycoside hydrolase, family 37 |
| 31 | 34 | Phobius | SIGNAL_PEPTIDE_C_REGION | C-terminal region of a signal peptide. |
| 451 | 460 | ProSitePatterns | PS00928 | Trehalase signature 2. |
| 451 | 460 | InterPro | IPR018232 | Glycoside hydrolase, family 37, conserved site |
| 43 | 547 | FunFam | G3DSA:1.50.10.10:FF:000003 | Cytoplasmic trehalase |
| 43 | 544 | SUPERFAMILY | SSF48208 | Six-hairpin glycosidases |
| 43 | 544 | InterPro | IPR008928 | Six-hairpin glycosidase superfamily |
| 44 | 537 | PANTHER | PTHR23403 | TREHALASE |
| 44 | 537 | InterPro | IPR001661 | Glycoside hydrolase, family 37 |
| 1 | 17 | Phobius | SIGNAL_PEPTIDE_N_REGION | N-terminal region of a signal peptide. |
| 60 | 537 | Pfam | PF01204 | Trehalase |
| 60 | 537 | InterPro | IPR001661 | Glycoside hydrolase, family 37 |
| 1 | 34 | SignalP_GRAM_POSITIVE | SignalP-TM | SignalP-TM |
| 542 | 581 | MobiDBLite | mobidb-lite | consensus disorder prediction |
| 2 | 539 | Hamap | MF_01060 | Periplasmic trehalase [treA]. |
| 2 | 539 | InterPro | IPR023720 | Trehalase, periplasmic |
| 35 | 581 | Phobius | NON_CYTOPLASMIC_DOMAIN | Region of a membrane-bound protein predicted to be outside the membrane, in the extracellular region. |
| 154 | 167 | ProSitePatterns | PS00927 | Trehalase signature 1. |
| 154 | 167 | InterPro | IPR018232 | Glycoside hydrolase, family 37, conserved site |
| 1 | 34 | Phobius | SIGNAL_PEPTIDE | Signal peptide region |
| 39 | 552 | Gene3D | G3DSA:1.50.10.10 | - |
| 39 | 552 | InterPro | IPR012341 | Six-hairpin glycosidase-like superfamily |
| 18 | 30 | Phobius | SIGNAL_PEPTIDE_H_REGION | Hydrophobic region of a signal peptide. |
3D structure
Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; AlphaFold DB and ColabFold models typically cover the full protein but remain computational predictions.
How colors and pocket overlays are used
Pocket details Inspect a specific pocket, or open the full viewer
- Method
- -
- Score
- -
- Visible layer
- -
- Residues
- -
- Pocket properties
- -
Selecting a pocket opens its details and centers the viewer without clearing other active layers. Use Focus this pocket when you want to hide the rest; use Surface for the wider residue environment.
Binding pockets · FPocket
Druggability: high ≥ 0.7 · medium 0.4–0.69 · low < 0.4
Binding pockets · P2Rank
Probability: high ≥ 0.5 · medium 0.2–0.49 · low < 0.2
Residue sets
Binding pockets · FPocket
Druggability: high ≥ 0.7 · medium 0.4–0.69 · low < 0.4
Binding pockets · P2Rank
Probability: high ≥ 0.5 · medium 0.2–0.49 · low < 0.2
All structural evidence
Structural evidence
0 + 2Experimental PDB entries plus predicted AlphaFold DB or ColabFold models. Click Switch to display a different loaded structure in the viewer.
| Entry | Method | Resolution | Chain | Coverage | Links | Status |
|---|---|---|---|---|---|---|
|
AlphaFold DB
AF_A0A0H3GV93
|
AlphaFold DB | — | — | full sequence | — | Viewing |
|
ColabFold
KP13_01544
|
ColabFold | — | — | full sequence | — | Loaded |
Ligand evidence
Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.
Structural and bioactivity evidence are both available for this target.
Highest-confidence structural evidence: ligands co-crystallized with this exact protein. If the source PDB is loaded in Target, use Open crystal to inspect it in the structure viewer.
No PDB structure with a co-crystallized ligand found for this exact protein.
Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.
Experimental bioactivity from ChEMBL measured directly on this protein. Score = pchembl (−log Ki/IC₅₀; higher = more potent).
No ChEMBL bioactivity data found for this exact protein.
Bioactivity inferred from similar proteins in ChEMBL. Score = pchembl (−log Ki/IC₅₀; higher = more potent).
| Ligand | UniProt (homolog) | pchembl | MW · LogP · TPSA | Lipinski | PAINS | SMILES |
|---|---|---|---|---|---|---|
| VDM ChEMBL | O70282 | 8.31 ~4.9 nM | 335.4 Da LogP -4.58 TPSA 173.9 | 1 viol. | ✓ Clean |
C1[C@@H]([C@H]([C@@H]([C@H]([C@H]1N[C@H]2C=C([C…
|
| CHEMBL2270892 ChEMBL | P32358 | 7.31 ~49.0 nM | 366.3 Da LogP -6.04 TPSA 204.7 | 2 viol. | ✓ Clean |
OC[C@H]1O[C@H](NC2=N[C@@H]3[C@H](O2)[C@@H](O)[C…
|
| CHEMBL145196 ChEMBL | O43280 | 6.75 ~177.8 nM | 321.3 Da LogP -4.56 TPSA 162.9 | 1 viol. | ✓ Clean |
OCC1=CC(NC2COC(CO)C(O)C2O)C(O)C(O)C1O
|
Proposed virtual-screening candidates from ZINC. Score = Tanimoto similarity to a known binder (0–1; higher = more similar).
| Ligand | Tanimoto | MW · LogP · TPSA | Lipinski | PAINS | SMILES |
|---|---|---|---|---|---|
| ZINC1857787936 ZINC | 0.647 | 497.5 Da LogP -6.75 TPSA 253.0 | 2 viol. | ✓ Clean |
OCC1=C[C@@H](N[C@@H]2C[C@@H](CO)[C@H](O[C@H]3O[…
|
| ZINC2053528368 ZINC | 0.647 | 497.5 Da LogP -6.75 TPSA 253.0 | 2 viol. | ✓ Clean |
OCC1=C[C@@H](N[C@@H]2C[C@H](CO)[C@@H](O[C@H]3O[…
|
| ZINC2053528371 ZINC | 0.647 | 497.5 Da LogP -6.75 TPSA 253.0 | 2 viol. | ✓ Clean |
OCC1=C[C@@H](N[C@@H]2C[C@H](CO)[C@@H](O[C@H]3O[…
|
| ZINC2053528373 ZINC | 0.647 | 497.5 Da LogP -6.75 TPSA 253.0 | 2 viol. | ✓ Clean |
OCC1=C[C@@H](N[C@@H]2C[C@H](CO)[C@@H](O[C@H]3O[…
|
| ZINC2053528375 ZINC | 0.647 | 497.5 Da LogP -6.75 TPSA 253.0 | 2 viol. | ✓ Clean |
OCC1=C[C@@H](N[C@@H]2C[C@H](CO)[C@@H](O[C@H]3O[…
|
| ZINC8437016 ZINC | 0.647 | 497.5 Da LogP -6.75 TPSA 253.0 | 2 viol. | ✓ Clean |
OCC1=C[C@H](N[C@H]2C[C@H](CO)[C@@H](O[C@@H]3O[C…
|
| ZINC16052241 ZINC | 0.600 | 335.4 Da LogP -4.58 TPSA 173.9 | 1 viol. | ✓ Clean |
OCC1=C[C@H](N[C@H]2C[C@H](CO)[C@@H](O)[C@H](O)[…
|
| ZINC71773889 ZINC | 0.526 | 206.1 Da LogP -1.77 TPSA 132.1 | ✓ Ro5 | ✓ Clean |
O=C(C[C@H](O)C(=O)O)C[C@H](O)C(=O)O
|
| ZINC71773890 ZINC | 0.526 | 206.1 Da LogP -1.77 TPSA 132.1 | ✓ Ro5 | ✓ Clean |
O=C(C[C@H](O)C(=O)O)C[C@@H](O)C(=O)O
|
| ZINC71773891 ZINC | 0.526 | 206.1 Da LogP -1.77 TPSA 132.1 | ✓ Ro5 | ✓ Clean |
O=C(C[C@@H](O)C(=O)O)C[C@@H](O)C(=O)O
|
PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.